(Q47635662)

4 February 2018

title

Association between percentage of tumor involvement and Gleason score upgrading in low-risk prostate cancer (English)

1 reference

4 February 2018

author name string

Qiang Fu

1

1 reference

4 February 2018

Judd W Moul

2

1 reference

4 February 2018

Lionel L Bañez

3

1 reference

4 February 2018

Leon Sun

4

1 reference

4 February 2018

Vladimir Mouraviev

5

1 reference

4 February 2018

Dongha Xie

6

1 reference

4 February 2018

Thomas J Polascik

7

1 reference

4 February 2018

publication date

12 June 2012

1 reference

4 February 2018

published in

Medical Oncology

1 reference

4 February 2018

volume

29

1 reference

4 February 2018

issue

5

1 reference

4 February 2018

page(s)

3339-3344

1 reference

4 February 2018

https://scigraph.springernature.com/pub.10.1007/s12032-012-0270-4

exact match

0 references

cites work

Contemporary trends in low risk prostate cancer: risk assessment and treatment

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0270-4

Active surveillance for favorable risk prostate cancer: what are the results, and how safe is it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0270-4

Outcomes in localized prostate cancer: National Prostate Cancer Register of Sweden follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0270-4

Discrepancies between Gleason scores of needle biopsy and radical prostatectomy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0270-4

20-year outcomes following conservative management of clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0270-4

Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0270-4

Tumor volume, tumor percentage involvement, or prostate volume: which is predictive of prostate-specific antigen recurrence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0270-4

Contemporary risk profile of prostate cancer in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0270-4

Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0270-4

Active surveillance for prostate cancer: for whom?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0270-4

Prediction of Gleason score upgrading in low-risk prostate cancers diagnosed via multi (> or = 12)-core prostate biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0270-4

Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0270-4

Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0270-4

Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0270-4

Small Transrectal Ultrasound Volume Predicts Clinically Significant Gleason Score Upgrading After Radical Prostatectomy: Results From the SEARCH Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-012-0270-4

Prostate biopsy clinical and pathological variables that predict significant grading changes in patients with intermediate and high grade prostate cancer

21 January 2018

1 reference

12 December 2020

Prostate cancer laterality does not predict prostate-specific antigen recurrence after radical prostatectomy

1 reference

12 December 2020

Clinical predictors of upgrading to Gleason grade 4 or 5 disease at radical prostatectomy: potential implications for patient selection for radiation and androgen suppression therapy

1 reference

12 December 2020

Early stage prostate cancer--do we have a problem with over-detection, overtreatment or both?

1 reference

12 December 2020

Prognostic significance of Gleason score discrepancies between needle biopsy and radical prostatectomy

1 reference

12 December 2020

10.1007/S12032-012-0270-4

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018